DYFENAMIC CAPSULE 250 MG

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Bahan aktif:

MEFENAMIC ACID

Boleh didapati daripada:

DYNAPHARM (M) SDN BHD

INN (Nama Antarabangsa):

MEFENAMIC ACID

Unit dalam pakej:

500 Capsule Capsules; 1000 Capsule Capsules

Dikeluarkan oleh:

DYNAPHARM (M) SDN BHD

Risalah maklumat

Consumer Medication Information Leaflet (RiMUP)
DYFENAMIC TABLET / CAPSULE
Mefenamic Acid (250 mg, 500 mg)
1
What is in this leaflet
1.
What Dyfenamic is used for
2.
How Dyfenamic works
3.
Before you use Dyfenamic
4.
How to use Dyfenamic
5.
While you are using it
6.
Side effects
7.
Storage and Disposal of Dyfenamic
8.
Product Description
9.
Manufacturer and Product
Registration Holder
10.
Date of revision
What Dyfenamic is used for
Dyfenamic is used to treat mild to
moderate pain from various conditions.
How Dyfenamic works
Mefenamic acid works by reducing the
pain and inflammation.
Before you use Dyfenamic
-
When you must not use it
Do not use Dyfenamic if you have:
•
Ulceration or inflammation of
gastrointestinal tract.
•
Allergic to Mefenamic Acid
Pregnancy and lactation
Do not take Dyfenamic if you are
pregnant, trying to get pregnant or think
you may be pregnant.
Do not take Dyfenamic if you are breast-
feeding. Ask your doctor or pharmacist
for advice before taking any medicine.
-
Before you start use it
It should be given with care to patients
with bleeding disorders, cardiovascular
disease, peptic ulceration or a history of
such ulceration, and in those who are
receiving coumarin anticoagulants.
-
Taking other medicines
Mefenamic Acid may enhance the
effects of the coumarin anticoagulants.
Tell your doctor if you are taking any
other medicines, including any that you
buy without a prescription from a
pharmacy, supermarket or health food
shop.
How to use Dyfenamic
-
How much to use
Follow all directions given to you by
your doctor and pharmacist carefully.
They may differ from the information
contained in this leaflet. If you do not
understand the instructions on the label,
ask your doctor or pharmacist for help.
Adults: Pain - 500 mg initially, followed
by 250 mg every 6 hours as necessary.
Treatment should not be continued for
longer than 7 days.
Menstrual cramps- Medication should
be initiated with the onset of bleeding
and associated symptoms and should not
be necessary for more than 2 - 3 days.
Ch

Ciri produk

DYFENAMIC
DESCRIPTION
CONTENT
DYFENAMIC CAPSULE
250MG
MAL19910013AZ
SIN8342P
CAPSULE
Capsule Colour
:
Ivory/Blue
Capsule Size
:
# 1
Granules Colour :
White To Off-white
Each Capsule Contains:
Mefenamic Acid ..............250 mg
DYFENAMIC TABLET
250MG
MAL19910165AZ
TABLET
Colour
:
Yellow
Shape
:
Round and Biconvex
Coating :
Film-coated
Each Tablet Contains:
Mefenamic Acid ..............250 mg
DYFENAMIC TABLET
500MG
MAL19910166AZ
TABLET
Colour
:
Yellow
Shape
:
Oval, Biconvex and Scored
Coating :
Film-coated
Each Tablet Contains:
Mefenamic Acid ..............500 mg
PHARMACODYNAMICS:
Analgesic action: It may block out pain impulse generation via a
peripheral action which may involve inhibition
of the synthesis of prostaglandins, and possibly inhibition of the
synthesis or action of other substances which
sensitise pain receptors to mechanical or chemical stimulation.
Anti-inflammatory action: It may act peripherally in inflamed tissue,
probably by inhibiting the synthesis of
prostaglandins and possibly by inhibiting the synthesis and/or actions
of
other local mediators of the
inflammatory response.
PHARMACOKINETICS:
Mefenamic Acid is absorbed from the GIT. Peak concentrations on the
circulation occur about 2 hours after
ingestion. Mefenamic Acid is extensively bound to plasma proteins.
Approximately 50% of a dose may be
recovered in the urine within 48 hours, mainly as conjugated
metabolites.
INDICATIONS:
Mild to moderate pain such as muscular aches, backaches, dental pain,
bursitis, dysmenorrhoea, rheumatic
pain, traumatic pain, headaches of most aetiology, postoperative and
postpartum pain, rheumatoid arthritis
(including Still’s disease) osteoarthritis and menorrhagia due to
dysfunctional causes.
RECOMMENDED DOSAGE:
Adults: Pain - 500 mg initially, followed by 250 mg every 6 hours as
necessary. Treatment should not be
continued for longer than 7 days.
Dysmenorrhoea - Medication should be initiated with the onset of
bleeding and associated symptoms and should
not be necessary for more than 2 - 3 days.
Children wi